Pharma Industry Braces as Dems Hash Out Drug Price Package
Although House Democratic leaders recently suffered a setback when a trio of moderates in a key committee voted against a sweeping set of drug pricing reforms, health care policy experts tell AIS Health that the pharmaceutical industry has every reason to be worried about the prospect of government price controls becoming law.
As one Capitol Hill insider put it: “The drug lobby has never been as worked up and worried before as they are right now, and the reason is because there is an extreme likelihood that something is going to pass.”
© 2024 MMIT